Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy and the safety of Avanafil 100mg, 200mg
or placebo administered orally for 12 weeks in patients with erectile dysfunction. The
efficacy is evaluated by IIEF, SEP Q2 and Q3 and GEAQ and the safety is evaluated by
laboratory tests, vital signs, physical examination and adverse events.